12:00 AM
Dec 19, 2011
 |  BC Week In Review  |  Company News  |  Other News

Callisto, Ironwood gastrointestinal news

Synergy Pharmaceuticals Inc. (OTCQB:SGYPD, New York, N.Y.), which is majority owned by Callisto, filed a suit in the N.Y. State Supreme Court against Ironwood and its SVP of R&D and Chief Scientific Officer Mark Currie. The suit alleges that statements made by Ironwood to the European Patent Office and the U.S. Patent and Trademark Office in opposition to patents covering Synergy's...

Read the full 291 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >